Czechia· CZ-0238319
DELSTRIGO
A lamivudine, tenofovir disoproxil and doravirine product containing doravirine + lamivudine + tenofovir disoproxil fumarate, registered in Czechia by Merck Sharp & Dohme B.V., Haarlem. The same ATC class is registered in 13 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Lamivudine, tenofovir disoproxil and doravirine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR24 (lamivudine, tenofovir disoproxil and doravirine), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Lamivudine, tenofovir disoproxil and doravirine · ATC J05AR24
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- DORAVIRINE + LAMIVUDINE + TENOFOVIR DISOPROXIL FUMARATE
- Manufacturer
- Merck Sharp & Dohme B.V., Haarlem
- Country
- Czechia (CZ)
- ATC code
- J05AR24
- ATC class
- Lamivudine, tenofovir disoproxil and doravirine
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl023831930CZK 13502.99
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudine, tenofovir disoproxil and doravirine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandDelstrigoMerck Sharp & Dohme B.V.
- FinlandDelstrigoMerck Sharp & Dohme B.V.
- United StatesDELSTRIGOMerck Sharp & Dohme LLC
- FranceDELSTRIGO 100 mg/300 mg/245 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
- United KingdomDelstrigo 100mg/300mg/245mg tabletsMerck Sharp & Dohme (UK) Ltd
- CanadaDELSTRIGOMERCK CANADA INC
- IcelandDelstrigoMerck Sharp & Dohme B.V.*
- NorwayDelstrigoMerck Sharp & Dohme Ltd (1)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Delstrigo
- Liechtenstein · Delstrigo
- Norway · Delstrigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6777449-cbbd-4f0d-9214-e5b71b8c245c GET /v1/drugs/b6777449-cbbd-4f0d-9214-e5b71b8c245c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "100MG/300MG/245MG",
"pack_size": "30",
"substance": "DORAVIRINE + LAMIVUDINE + TENOFOVIR DISOPROXIL FUMARATE",
"cz_kod_sukl": "0238319",
"product_type": "CH",
"substance_codes": "20183,12280,16950",
"registration_state": "R",
"registration_number": "EU/1/18/1333/001"
}See everything about lamivudine, tenofovir disoproxil and doravirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.